Today’s CGMs measure glucose through fluid under the skin—but what if we could measure it directly from the blood? Today we explore Glucotrack, an implantable device that could become the world’s first continuous blood glucose monitor (CBGM). I’m joined by Glucotrack's CEO and Chief Scientific Officer to discuss the major advantages this device could offer over today’s CGMs. We cover how the sensor works, how it's implanted, and its potential to improve accuracy and supercharge automated insulin delivery. 

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up  (US residents only)

Watch This Episode On Youtube

Join our Newsletter | Support us on Patreon 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.